TG Therapeutics, Inc. (TGTX) NASDAQ
33.73
-0.9(-2.60%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.3B |
| Enterprise Value | 4.48B |
| P/E Ratio | 10.96 |
| PEG Ratio | 0.11 |
| Price/Sales Ratio | 8.88 |
| Price/Book Ratio | 7.56 |
| Enterprise/Revenue | 9.18 |
| Enterprise/EBITDA | 42.09 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.73 |
| Operating Margin | 0.2 |
Management Effectiveness
| Return On Assets | 0.42 |
| Return On Equity | 1.01 |
Income Statement
| Revenue | 616.29M |
| Revenue/Share | 4.31 |
| Gross Profit | 515.33M |
| EBITDA | 134.36M |
| Net Income | 447.18M |
| Diluted EPS | 2.77 |
Balance Sheet
| Total Cash | 141.97M |
| Total Cash/Share | 0.99 |
| Total Debt | 260.73M |
| Total Debt/Equity | 0.4 |
| Current Ratio | 4.1 |
| Book Value Per Share | 4.53 |
Price History
| 52-Week Change | -4.72 |
| 52-Week High | 46.48 |
| 52-Week Low | 25.28 |
| Moving Average 50 Days | 30.12 |
| Moving Average 200 Days | 32.03 |
Statistics
| Average Volume | 2.09M |
| Shares Outstanding | 159.69M |
| % Held by Institutions | 70.91 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 4:225 |
| Last Split Date | April 30, 2012 |
